Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
March 22 Product: J&Js Opsynvi Indication: Pulmonary arterial hypertension Setting up a big week for the pulmonary arterial hypertension (PAH) space, the FDA approved Johnson & Johnsons single-tablet combination therapy of macitentan and tadalafil for the cardiac disease
A synthetic 15-amino-acid sequence derived from a protective compound in gastric juice, it shows consistent results across animal studies for tendon, ligament, muscle, bone, and GI tissue repair through angiogenesis, collagen organization, and inflammation control
Insomnia in patients with coronary heart disease: prevalence and correlates
DSIP (Delta Sleep-Inducing Peptide) Sleep disorders affect a significant percentage of individuals with ASD
Philadelphia: W.B
Our Vitamin B12 therapy is dispensed by a nurse practitioner, making it safe and effective
US$ 25.64
US$ 29.21
US$ 27.26
US$ 29.44